Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis
- 31 December 1995
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 23 (6), 674-680
- https://doi.org/10.1016/0168-8278(95)80033-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Indications for liver transplantation in primary biliary cirrhosisHepatology, 1994
- Autoantibody against dihydrolipoamide dehydrogenase, the E3 subunit of the 2-oxoacid dehydrogenase complexes: Significance for primary biliary cirrhosisHepatology, 1991
- Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosisJournal of Clinical Immunology, 1991
- Is PBC cured by liver transplantation?The Lancet, 1991
- Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complexHepatology, 1989
- Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain α-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigenHepatology, 1989
- Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Primary Biliary CirrhosisNew England Journal of Medicine, 1987
- Antimitochondrial antibodies in primary biliary cirrhosisJournal of Hepatology, 1986
- Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patientsGastroenterology, 1985